Last reviewed · How we verify
NCT07112677
Seroprevalence of Brucella Antibodies in High-Risk Patients With Low Back Pain: A Case-Control Study
trial testing Brucella Antibody Testing (ELISA) in Brucellosis in 100 participants. Completed in 28 February 2025.
28 February 2025
Quick facts
| Lead sponsor | Elham Ahmed Hassan |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 February 2024 |
| Primary completion | 28 February 2025 |
| Estimated completion | 28 February 2025 |
| Sites | 2 locations across Egypt |
Drugs / interventions tested
- Brucella Antibody Testing (ELISA)
Conditions studied
- Brucellosis — all drugs for Brucellosis →
- Low Back Pain — all drugs for Low Back Pain →
Sponsor
Elham Ahmed Hassan
Who can join
18 and older, any sex, with Brucellosis or Low Back Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational case-control study is to assess the presence of Brucella antibodies in patients with low back pain who are at high risk for brucellosis exposure, such as those with animal contact or consumption of unpasteurized dairy products. The main question it aims to answer is: Is there a significant association between Brucella seropositivity and low back pain in high-risk individuals? Researchers will compare patients with low back pain to age- and sex-matched healthy controls without back pain but with similar exposure risks, to see if Brucella antibodies are more frequent in the patient group. Participants will: Undergo a detailed clinical history and physical examination Provide blood samples for serological testing using ELISA for Brucella IgG/IgM/IgA Be evaluated for other symptoms such as fever, fatigue, and joint pain
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07112677
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Brucellosis
Currently open trials in the same condition.
- NCT07358910 — Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07112677 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Elham Ahmed Hassan
- Last refreshed: 8 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07112677.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing